Biotech

All Articles

A closer check out Fierce Biotech's Ferocious 15

.Within this full week's episode of "The Best Pipe," our experts're diving in to Fierce Biotech's an...

Lilly experiences period 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's gathering celebrating the commendation of Alz...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings ...

Lykos will certainly ask FDA to rethink its own decision following turndown of MDMA therapy for post-traumatic stress disorder

.Complying with an inadequate showing for Lykos Therapies' MDMA prospect for post-traumatic stress d...

AN 2 fifty percents headcount, stops phase 3 test after information dissatisfy

.AN2 Therapeutics is reassessing its service in response to dull midphase information, pledging to l...

Merck spends $700M for bispecific, spying autoimmune opening as well as possibility to challenge Amgen in cancer

.Merck &amp Co. is paying $700 million beforehand to challenge Amgen in a blood cancer market. The b...

Gilead pays J&ampJ $320M to go out licensing deal for seladelpar

.Along With Gilead Sciences about to an FDA decision for its own liver illness medicine seladelpar, ...

' All hands on deck' at Lilly as peers target being overweight market

.CEO David Ricks may find the providers putting together outdoors tents at basecamp responsible for ...

Entero giving up workers, abandoning workplace as well as pausing R&ampD

.Bed mattress Liquidators has actually switched Entero Rehabs white as a sheet. The lender ordered E...

Exelixis goes down ADC after deciding it is actually no match for Tivdak

.Exelixis is giving up on its own tissue factor (TF)- targeting antibody-drug conjugate after conclu...